In this video, Dr. Patrick Nemechek gives a clinical overview of how small intestine bacterial overgrowth (SIBO) may affect key neurodevelopmental features seen in autism. He frames SIBO as more than a GI issue—describing a downstream pattern involving bacterial byproducts, intestinal permeability, inflammation, and changes in nervous system function.
Rather than presenting autism as a collection of unrelated symptoms, Dr. Nemechek explains a simplified clinical model: he describes “two things” (bacterial byproducts and inflammation) contributing to a consistent set of developmental and autonomic findings across children with autism.
What Dr. Nemechek means by SIBO
Dr. Nemechek defines SIBO as a shift in where bacteria are concentrated in the digestive tract. In his illustration, the small intestine normally contains relatively few bacteria compared with the large intestine. He describes this as a large ratio difference between the two locations. In SIBO, he says, one or two species overgrow in the small intestine—described as reaching extremely high levels compared with normal.
In his clinical explanation, this overgrowth is important because it can lead to:
- Increased intestinal permeability (often referred to as “leaky gut”)
- Inflammation
- Production of propionic acid as a bacterial byproduct (which he specifically discusses “in the case of autism”)
A proposed three-part clinical picture: cognition, pruning, and autonomic function
Dr. Nemechek describes a clinical sequence in which SIBO contributes to both inflammation and propionic acid production. In his framework, those factors are then linked to three broad areas of function that clinicians and families often notice:
1) Altered cognitive function (propionic acid)
Dr. Nemechek states that propionic acid can have a major effect on cognitive function. He uses a vivid analogy, describing it as “a cross between Valium and LSD,” and suggests that some children can appear markedly different over a short period of time as bacterial production increases. In his interpretation, the child can seem “drugged” by a chemical byproduct from bacteria.
2) Developmental delay through disrupted “pruning” (inflammation)
He also attributes a central role to inflammation. Dr. Nemechek explains that normal neurodevelopment involves the brain “pruning” neural connections—describing it as going from roughly 100 billion neurons to 50 billion as part of meeting developmental milestones. In his clinical model, inflammation interferes with this pruning, contributing to developmental delay.
3) Autonomic nervous system dysfunction and cerebral hypoperfusion
In addition, Dr. Nemechek links inflammation (along with propionic acid) to autonomic nervous system dysfunction. He describes the primary feature he sees as low blood pressure in the brain, which he refers to as cerebral hypoperfusion. He connects this pattern with a range of concerns commonly reported in autism, including:
- Profound attention problems / ADD
- Hyperactivity
- Sleep difficulties
- Anxiety
- Aggression
He also mentions constipation as a “notorious problem” in autism and includes it as part of this overall clinical picture.
What he reports when SIBO is reversed
Dr. Nemechek then discusses what he observes clinically when SIBO is treated using inulin or rifaximin. In the video, he describes these interventions as reversing the bacterial imbalance (his visual shorthand is “fish with the birds” returning to the expected locations).
In his account, reversing SIBO influences the same three areas he outlined earlier:
Propionic acid effects: an “awakening phase”
He states that when SIBO is reversed, propionic acid is no longer released into the bloodstream and “goes out of their bloodstream.” Dr. Nemechek describes many children as “waking up,” sometimes with an “impressive awakening phase” over the first couple of weeks. The examples he gives include improved eye contact and better response to their name.
Inflammation and pruning: developmental progress
As inflammation drops, he says normal pruning can resume, and children may begin hitting developmental milestones again.
Autonomic recovery: improved regulation and behavior
Dr. Nemechek adds that as inflammation decreases, he says the autonomic nervous system can recover, with improving blood pressure regulation. In his description, this may correspond to less hyperactivity, less anxiety, less aggression, and less ADHD-type impairment. He also notes improved intestinal motility and constipation that lessens or resolves.
How he interprets response to treatment
Dr. Nemechek emphasizes a clinical interpretation: he states that if inulin or rifaximin are used, “the only thing they can do is reverse SIBO.” In the video, he concludes that a positive response to those interventions “proves your kid has SIBO.”
Medical disclaimer
Educational only: This article summarizes statements from a video by Dr. Patrick Nemechek and is not medical advice. SIBO, autism, and related symptoms require individualized evaluation and care from a licensed clinician.